Controlled Antenatal Thyroid Study: Obstetric Outcomes

Research output: Contribution to journalAbstract

Authors

  • Peter Taylor
  • Arron Lacey
  • Daniel Thayer
  • Mohd Yusof
  • Arshiya Tabasum
  • Illaria Muller
  • Luke Marsh
  • Marian Ludgate
  • Alex Rees
  • Scott Nelson
  • Aled Rees
  • John Lazarus
  • Colin Dayan
  • Bijay Vaidya
  • Onyebuchi Okosieme

Colleges, School and Institutes

External organisations

  • Swansea Univ
  • Cardiff University
  • University Hospital of Wales, Cardiff, UK.
  • University of Glasgow
  • Royal Devon and Exeter Hospital

Abstract

Background
Suboptimal thyroid function in pregnancy is associated with adverse obstetric outcomes but it is unclear whether levothyroxine treatment, initiated during pregnancy is beneficial. We investigated whether correction of abnormal thyroid function during pregnancy is associated with improved obstetric outcomes.
Methods
Retrospective analysis of the Controlled Antenatal Thyroid Screening (CATS) study with obstetric outcomes obtained through data-linkage in the Secure Anonymised Information Linkage (SAIL) databank. Setting: Welsh participants from CATS. Participants: 13,506 pregnant women; 12,874 women had normal thyroid function, 320 had subclinical hypothyroidism (SCH), 281 had isolated hypothyroxinemia (IH) and 31 had overt hypothyroidism. Main Outcome Measures: Odds of stillbirths (fetal demise after 24 weeks gestation), Caesarean sections, prematurity and abnormal birth-weight by thyroid and treatment status.
Results
Untreated women with SCH had increased odds of stillbirth compared to women with normal thyroid function OR = 5.73 (95%CI 1.74, 18.9) p = 0.003. No stillbirths occurred in women receiving levothyroxine. In analysis of women with IH, untreated women had an increased risk of early (≤37 weeks) caesarean section than those who received levothyroxine (6% vs 0%) p = 0.006. Untreated women with IH also had earlier mean gestational age 38.8 (SD 2.34) weeks vs. 39.7 (SD 1.94) weeks p = 0.002 and lower mean birth-weight 3353 g (SD 639) vs. 3558 g (SD 532) p = 0.004.
Conclusion
Both SCH and IH are associated with adverse obstetric outcomes. In IH levothyroxine treatment is associated with favourable effects on, gestational age at delivery and early Caesarean section rates. Levothyroxine may also have some protective impact on stillbirths in SCH.

Details

Original languageEnglish
Article numberO1
Pages (from-to)2
Number of pages1
JournalThyroid Research
Volume10(Suppl 1)
Issue number2
Publication statusPublished - 13 Feb 2017